Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Named one of the fastest-growing private companies in America.
August 18, 2020
By: Contract Pharma
Contract Pharma Staff
Swiss American CDMO, a Dallas-based company that specializes in topical skin care, OTC drugs, medical devices and wound care products, was ranked No. 3290 on the 2020 Inc. 5000 list. The 2020 list recognizes revenue growth from 2016-2019 among US-based, privately held, independent companies. Swiss-American was one of six skin care/personal care manufacturers to make the list, and the only Texas-based skin care/personal care manufacturer. “We are honored to be recognized on the notable Inc. 5000 list for the second consecutive year,” said Philip O’Neill, CEO of Swiss-American. “This recognition is a testament to our dedicated team of experts who remain at the forefront of the CDMO industry, identifying advanced topical solutions for a variety of disease states, therapeutic areas and global marketplaces.” Swiss American CDMO partners with multinational customers to develop and manufacture topical sun, skin and wound care products in the over-the counter (OTC) drug, medical device and personal care markets. The company generated a compound annual growth rate of more than 29% over the past three years. While the new Inc. 5000 list does not reflect this year’s revenue data, the global pandemic created new challenges for all businesses in 2020. As a high-performing, fast-growth company, Swiss-American has learned to adapt to rapidly changing business circumstances. “Swiss American CDMO is thankful for our network of customers that enabled our 2016-2019 growth and extremely proud to have continued our business operations uninterrupted, as an essential business, throughout 2020,” said Komel Grover, president of Swiss-American. “We continue to adapt and learn in these unprecedented times by applying our expertise to new areas of development to service the needs of new and existing customers. We continue to innovate and prepare for the future, so we can address the post-COVID-19 marketplace and consumer needs effectively for our customers. We stand ready for the future.” Over the past decade, this is the third time Swiss American CDMO has been included in the annual Inc. 5000 ranking.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !